PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+89.21%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$76.6M
AUM Growth
+$76.6M
(+26%)
Cap. Flow
-$29.5M
Cap. Flow
% of AUM
-38.46%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
Dare Bioscience
DARE
|
$1 |
Top Sells
| 1 |
Fate Therapeutics
FATE
|
$25.9M |
| 2 |
Neuronetics
STIM
|
$3.56M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Fate Therapeutics
FATE
$120M
| $51.8M | 67.63% | 569,889 -284,947 | -33% | -$25.9M |
|
2
Lyra Therapeutics
LYRA
$11.5M
| $12.6M | 16.38% | 1,100,852 | – | – |
|
3
Cartesian Therapeutics
RNAC
$261M
| $8.4M | 10.97% | 2,773,479 | – | – |
|
4
X4 Pharmaceuticals
XFOR
$84.2M
| $2M | 2.61% | 311,492 | – | – |
|
|
ATYR
5
aTyr Pharma
ATYR
$527M
| $507K | 0.66% | 130,572 | – | – |
|
|
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
| $478K | 0.62% | 197,345 | – | – |
|
|
7
Dare Bioscience
DARE
$27.2M
| $437K | 0.57% | 326,241 +1 | +0% | +$1 |
|
8
Pulmatrix
PULM
$18M
| $428K | 0.56% | 359,441 | – | – |
|
|
9
Neuronetics
STIM
$220M
| – | – | -732,583 | Closed | -$3.56M |
|